Casdin Partners FO1-MSV, LP
- SEC CIK
- 0001938709
No open-market purchases or sales filed in the past year.
Current role at each company
- LAB Standard Biotools Inc.Directoras of Jun 21, 2024
- WGS GeneDx Holdings Corp.Directoras of Jun 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Casdin Partners FO1-MSV, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WGS GeneDx Holdings Corp.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 (view filing)8:45 PM ET | Jun 3-4 | 2 days | Casdin Partners GP, LLC and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +130.0K | $21.21 | +$2.76M | +4.4%3.09M after | 2 lots |
| May 31, 2024 (view filing)5:37 PM ET | May 29 | 2 days | Casdin Partners GP, LLC and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +40.0K | $21.07 | +$842.6K | +1.4%2.96M after | |
| May 28, 2024 (view filing)8:40 PM ET | May 23-28 | 5 days | Casdin Partners GP, LLC and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +170.0K | $20.15 | +$3.42M | +6.2%2.92M after | 3 lots |
| May 15, 2024 (view filing)6:16 PM ET | May 13 | 2 days | Casdin Partners GP, LLC and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +50.0K | $23.31 | +$1.17M | +1.8%2.75M after | |
| Mar 6, 2024 (view filing)7:32 PM ET | Mar 4-5 | 2 days | Casdin Partners GP, LLC and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +40.9K | $8.74 | +$357.7K | +1.5%2.70M after | 2 lots |
LAB Standard Biotools Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2024 (view filing)8:45 PM ET | May 23 | 5 days | Casdin Partners GP, LLC and 8 othersDirector, 10% Owner | PPurchase | +100.0K | $2.60 | +$260.0K | +0.2%46.1M after | |
| May 22, 2024 (view filing)7:53 PM ET | May 20-22 | 2 days | Casdin Partners GP, LLC and 8 othersDirector, 10% Owner | PPurchase | +600.0K | $2.57 | +$1.54M | +1.3%46.0M after | 3 lots |
| May 17, 2024 (view filing)8:11 PM ET | May 15-17 | 2 days | Casdin Partners GP, LLC and 8 othersDirector, 10% Owner | PPurchase | +1.35M | $2.56 | +$3.46M | +3.1%45.4M after | 3 lots |
| Mar 6, 2024 (view filing)7:20 PM ET | Mar 4-5 | 2 days | Casdin Partners GP, LLC and 8 othersDirector, 10% Owner | PPurchase | +251.4K | $2.57 | +$646.2K | +2.2%11.5M after | 2 lots |
| May 19, 2023 (view filing)9:00 PM ET | May 17-19 | 2 days | Casdin Partners GP, LLC and 5 othersDirector, 10% Owner | PPurchase | +1.20M | $2.19 | +$2.63M | New position1.20M after | 3 lots |